Bain Capital Life Sciences Leads $200M Growth Investment in Serán Bioscience

Ampersand Capital Partners Makes Growth Investment in VIVEbiotech

December 4, 2024

Biotechnology

Ampersand Capital Partners has made a growth equity investment in VIVEbiotech to support expansion of the company’s lentiviral vector development and GMP manufacturing capabilities in San Sebastián, Gipuzkoa, Spain. The investment will fund capacity growth and execution of VIVEbiotech’s pipeline of customer projects for cell and gene therapy developers, and industry veteran Dr. Stefan Beyer has been named Chairman.

Bain Capital Tech Opportunities Invests R$450M in Bionexo

October 15, 2021

Cloud & SaaS

Bain Capital Tech Opportunities has made a R$450 million growth investment in Bionexo, a São Paulo–headquartered healthcare cloud software and data analytics provider. The funding will be used to expand Bionexo's suite of healthcare SaaS products, accelerate AI/ML development, and pursue transformational M&A to deepen its marketplace and supply‑chain capabilities across Latin America.

Bain Capital Invests up to $300M in Cardurion Pharmaceuticals

October 27, 2021

Biotechnology

Cardurion Pharmaceuticals, a clinical‑stage biotechnology company focused on cardiovascular therapeutics, received a private investment of up to $300 million from Bain Capital Life Sciences and Bain Capital Private Equity to advance its PDE9 and CaMKII inhibitor programs and to scale the business. The funding will support a major Phase 2 heart‑failure trial, initiation of first‑in‑human studies, and company growth; Bain Capital will also join Cardurion’s board alongside existing investors Takeda Pharmaceuticals and Polaris Partners.

Ren Receives Strategic Growth Investment from Bain Capital Tech Opportunities and Valeas Capital Partners

July 26, 2023

Cloud & SaaS

Ren, an Indianapolis-based provider of donor-advised fund enablement software and services, received a strategic growth investment led by Bain Capital Tech Opportunities and Valeas Capital Partners. The capital — Ren's first institutional funding — will be used to build new product features, rapidly scale the team, increase advisor and client awareness of donor-advised funds, and expand Ren's charity network; financial terms were not disclosed. Raymond James acted as exclusive financial advisor.

Bain Capital Makes Significant Equity Investment in EcoCeres

January 12, 2023

Renewable Energy

Bain Capital Private Equity completed a significant equity investment in EcoCeres, an Asia-based advanced biorefinery platform that produces HVO, SAF and cellulosic ethanol from waste-based biomass. The investment will support EcoCeres’ international expansion and technology scaling to advance renewable fuels and decarbonization solutions.

SK bioscience Invests $3M in U.S. Biotech Fina Biosolutions

October 8, 2024

Biotechnology

SK bioscience has invested USD 3 million to acquire a stake in Fina Biosolutions (FinaBio), a Rockville, Maryland–based developer of conjugate vaccine technologies and CRM197 protein manufacturing. The strategic investment makes SK bioscience FinaBio's first strategic investor and is intended to accelerate commercialization of FinaBio's EcoCRM and conjugation technologies while enhancing SK bioscience's vaccine development and manufacturing capabilities.